Coronary arteriovenous fistula in pediatric patients: a 17-year institutional experience

Nan-Koong Wang1, Li-Yin Hsieh, Ching-Tsuen Shen

  • 1Department of Pediatrics, Cathay General Hospital, 280 Jen-Ai Road, Section 4, Taipei, Taiwan.

Insights

Pediatric coronary arteriovenous fistula (CAVF) often presents with symptoms, and surgical closure alone may not resolve fistula size. Long-term monitoring is crucial for managing potential complications like recanalization and thrombus formation.

Area of Science:

  • Pediatric Cardiology
  • Congenital Heart Disease
  • Vascular Surgery

Background:

  • Coronary arteriovenous fistula (CAVF) is a rare congenital anomaly in children.
  • Clinical presentations and long-term outcomes of pediatric CAVF are not fully understood.

Purpose of the Study:

  • To investigate the natural history and long-term outcomes of pediatric patients with CAVF.
  • To analyze treatment strategies and complications over a 17-year period.

Main Methods:

  • Retrospective review of medical records of 10 pediatric patients with CAVF.
  • Data collection included clinical presentation, diagnostic imaging (echocardiography, catheterization, angiography), and surgical outcomes.

Main Results:

  • CAVF diagnosed via echocardiography or cardiac catheterization/angiography.
  • Congestive heart failure, myocardial ischemia, and infarction were observed in some patients.
  • Postoperative complications included persistent dilation, recanalization, thrombus formation, calcification, and ventricular aneurysm.

Conclusions:

  • Pediatric CAVF patients are typically symptomatic, unlike adults.
  • Surgical ligation alone does not consistently reduce fistula size.
  • Long-term follow-up is essential to monitor for complications; antiplatelet therapy is recommended for specific cases.
Abstract

Related Concept Videos

Pharmacokinetics in Pediatric Patients: Drug Distribution01:17

Pharmacokinetics in Pediatric Patients: Drug Distribution

Drug distribution in the pediatric population exhibits unique challenges and considerations due to the physiological differences between children, particularly neonates and infants, and adults. A crucial aspect of pediatric pharmacology is understanding how these differences impact the pharmacokinetics of various drugs, necessitating age-specific dosing strategies to ensure efficacy and safety.Neonates and infants have a higher total body water content, ~75%–90% of their body weight,...
276
Pharmacokinetics in Pediatric Patients: Overview and Drug Absorption01:23

Pharmacokinetics in Pediatric Patients: Overview and Drug Absorption

Understanding the physiological differences in the pediatric population is crucial for effective pharmacotherapy. Neonates, infants, and children exhibit significant variations in gastric pH, gastric emptying time, intestinal transit time, and biliary function. These variations profoundly affect oral drug absorption, necessitating a nuanced approach to pediatric dosing.Neonates present with a unique physiological profile, having a gastric pH greater than 4 and faster and more irregular gastric...
261
Pharmacokinetics in Pediatric Patients: Drug Metabolism01:24

Pharmacokinetics in Pediatric Patients: Drug Metabolism

In pediatric care, understanding the nuances of hepatic drug metabolism is crucial, as it significantly differs from that of adults. This divergence is primarily due to the developmental stage of drug-metabolizing enzymes, which affects how medications are processed in the body. In neonates, for instance, the activity of Phase I enzymes—critical for the initial breakdown of drugs—is markedly reduced, functioning at just 20–40% of the levels seen in adults. This reduction poses...
200
Pharmacokinetics in Pediatric Patients: Drug Excretion01:26

Pharmacokinetics in Pediatric Patients: Drug Excretion

In pediatric medicine, understanding the renal function and drug elimination nuances is crucial for administering safe and effective treatments. Newborns, in particular, display markedly slower renal functions than adults, profoundly affecting how drugs are cleared from their bodies. This slower drug clearance requires clinicians to extend the dosing intervals for many medications to prevent drug accumulation and toxicity while ensuring therapeutic efficacy.One key area where these adjustments...
214
Coronary Circulation01:21

Coronary Circulation

The heart, an organ critical to survival, gets nourishment not from the blood it pumps but from a separate circulation system known as coronary circulation. This is the shortest circulation in the body and is responsible for supplying the heart with the nutrients it needs to function effectively.
Coronary circulation begins at the base of the aorta, where two main arteries arise—the left and right coronary arteries. These arteries encircle the heart in the coronary sulcus and supply the...
6.9K
What is an Experiment?01:12

What is an Experiment?

An experiment is a planned activity carried out under controlled conditions. The purpose of an experiment is to investigate the relationship between two variables. When one variable causes change in another, we call the first variable the explanatory or independent variable. The affected variable is called the response or dependent variable. In a randomized experiment, the researcher manipulates values of the explanatory variable and measures the resulting changes in the response variable. The...
17.5K